It's confusing. What we know so far:
- LCMD was public traded until it got suspended in 2015.
- LCMD stopped communicating on website, twitter and faceook in March 2017.
- LCMD LinkedIn page isn't updated for a long time (Preparation is underway to launch sales in the largest global markets, USA and Europe, in 2015)
- Prati updated his LinkedIn page for LCMD in 2017 (We began generating sales in 2017 and expect acceleration in 2018)
- The RM PR from February 2018 however mentioned only LCMD as a company, not Singular (Richard J. Prati has served as Chief Executive Officer of Life Care Medical Devices since 2013),
- Recently he updated his LinkedIn page saying he resigned as CEO for LCMD.-
- Last week NVSOS was updated with his name.
What to make of this? Obviously something went wrong with LCMD. My guess is they wanted to clean up the mess and make a fresh start under the QLIS umbrella, hence they mention it in the PR. So possibility 1 is that is done now, and possibility 2 is they couldn't get it fixed and decided to start a new company or merge Singular into it. But the fact that Prati is now listed as an officer on NVSOS (a year after the PR) means he didn't give up the ticker. It tells me he has a plan and is ready to let us know.
Whatever happens, looking at Prati's bio and all the connections he has, I think it will be good for us. We don't have to fear a RS: on the contrary, a FS is more likely.
AI
Market Data 
Markets 
